Bupropion Hydrobromide Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 75 mg, 100 mg, 150mg, 300 mg
Reference Brands: Wellbutrin (USA), Zyban (USA)
Category:
Antipsychotropic Drugs
Bupropion Hydrobromide is available in Tablets
and strengths such as 75 mg, 100 mg, 150mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bupropion Hydrobromide is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bupropion Hydrobromide can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Bupropion Hydrobromide, marketed under brand names such as Wellbutrin, is an atypical antidepressant primarily used for the treatment of major depressive disorder, seasonal affective disorder, and to support smoking cessation. It functions as a norepinephrine–dopamine reuptake inhibitor (NDRI), enhancing the levels of these neurotransmitters in the brain to improve mood and reduce depressive symptoms. Bupropion is often employed as an add-on therapy in patients who show an incomplete response to first-line selective serotonin reuptake inhibitors (SSRIs), providing additional symptom relief.
Unlike many other antidepressants, bupropion is associated with a lower risk of sexual dysfunction, weight gain, and sedation, making it a preferred option for patients concerned about these side effects. It is particularly effective in alleviating hypersomnia and fatigue, common symptoms in depressive disorders. Bupropion is available in immediate-release, sustained-release, and extended-release oral formulations, though the immediate-release form carries a higher risk of seizures and should be used cautiously in patients with a history of seizure disorders. Administered orally, bupropion offers a well-tolerated and versatile treatment option for depression, mood disorders, and smoking cessation support.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing